Enveric Biosciences Inc vs OneSpan Inc — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while OneSpan Inc trades at $15.47 (market cap $571.66M). The key difference: OneSpan Inc is far larger — about 107.5× Enveric Biosciences Inc's market cap, and OneSpan Inc pays a 3.37% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | OSPN | |
|---|---|---|
Market Cap | $5.32M | $571.66M |
Sector | Health | Technology |
52-Week High | $17.40 | $16.32 |
52-Week Low | $1.28 | $10.15 |
Enterprise Value | $408.82K | $529.87M |
Dividend Yield | — | 3.37% |
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →